<DOC>
	<DOC>NCT00941577</DOC>
	<brief_summary>To assess the efficacy of inhaled AIR645 in the suppression of the Asthmatic Responses in subjects with mild asthma inhaling an allergen.</brief_summary>
	<brief_title>Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Men and women with well controlled mild allergic asthma, aged 18 to 65 years Only asthma med is shortacting bronchodilator used not more than twice weekly FEV1 greater than 70% predicted and a demonstrated baseline late response to allergen induction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Hypersensitivity</keyword>
	<keyword>Lung Diseases, Obstructive</keyword>
	<keyword>Immune System Diseases</keyword>
	<keyword>Respiratory Tract Diseases</keyword>
	<keyword>Bronchial Diseases</keyword>
	<keyword>Lung Diseases</keyword>
	<keyword>Hypersensitivity, Immediate</keyword>
	<keyword>Asthma</keyword>
	<keyword>Respiratory Hypersensitivity</keyword>
</DOC>